Science just scored a win regarding the fight against end-stage kidney disease. The eGenesis company of Cambridge announced Sept. 8 that it had received clearance from the U.S. Food and Drug ...

IND supports Phase 1/2/3 study that will evaluate safety and efficacy at 24 weeks The first patient in the ongoing Multi-Patient Expanded Access study has surpassed seven months kidney function; a ...

- Transplant was conducted at Massachusetts General Hospital and authorized by the U.S. FDA under a single Expanded Access protocol CAMBRIDGE, Mass.--(BUSINESS WIRE)--eGenesis, a biotechnology company ...

Dr. Barth brings over 25 years of industry experience within the biotech and pharmaceutical sectors leading clinical development of transformational therapies eGenesis, a biotechnology company ...

A Cambridge biotech company and Boston doctors have received federal approval to start the nation’s first clinical trial of genetically engineered pig kidney transplants in people with end-stage ...

In a landmark move, the US Food and Drug Administration (FDA) has given biotech company eGenesis the go-ahead to conduct a broader human trial in pig-to-human kidney transplants, marking a significant ...

Biotech company eGenesis recently announced its implanted a pig kidney into a second human patient. This animal-to-human organ transplant, or xenotransplant, was made possible through advancements in ...

MASS GENERAL RIGHT NOW. DANNY AND DOCTORS HERE AT MASS GENERAL HAVE SUCCESSFULLY PERFORMED THREE TRANSPLANTS OF PIG KIDNEYS INTO HUMANS, AND A NEW FDA APPROVAL MAKES IT POSSIBLE FOR MORE PATIENTS TO ...

THE CHANCE OF FLAKES FOR SOME ON SUNDAY THAT’S COMING UP. NOW TO THE BREAKING NEWS. A NEW HAMPSHIRE MAN IS HOME RECOVERING IN CONCORD AFTER A HUMAN KIDNEY TRANSPLANT. JUST LAST YEAR, HE BECAME ONE OF ...

A biotech company recently announced that it's implanted another pig kidney into a human recipient. Here's what to know. Jesse Orrall (he/him/his) is a Senior Video Producer for CNET. He covers future ...